# Balkanpharma Dupnitsa AD – FDA Inspection, Sep 29, 2023

Source: https://www.keypedia.com/records/fda_inspections/balkanpharma-dupnitsa-ad/0617b475-59cf-4eb8-b3df-7c4fba341ed6
Source feed: FDA_Inspections

> FDA inspection 1222624 of Balkanpharma Dupnitsa AD, September 29, 2023. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1222624
- Company Name: Balkanpharma Dupnitsa AD
- Inspection Date: 2023-09-29
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1140148 - 2019-03-01
- FDA Inspection 1057710 - 2018-06-08
- FDA Inspection 1012588 - 2017-04-07
- [FDA Inspection 945384 - 2015-08-28](https://www.keypedia.com/records/fda_inspections/balkanpharma-dupnitsa-ad/2c31f66a-4897-40e5-8cf0-474da9609e3f)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/truong-x-nguyen/8f3aed17-0507-4272-a3b8-9188d761faed)

Company: https://www.keypedia.com/companies/balkanpharma-dupnitsa-ad/5cc89838-f87e-4692-a4a2-87d30a2b557b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c